• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global respiratory drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global respiratory drugs market 2017 – 2021 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ billion)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ billion)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Asthma – Market size and forecast 2022-2027
o Exhibit 52: Chart on Asthma – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Asthma – Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Asthma – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Asthma – Year-over-year growth 2022-2027 (%)
o 7.4 COPD – Market size and forecast 2022-2027
o Exhibit 56: Chart on COPD – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on COPD – Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on COPD – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on COPD – Year-over-year growth 2022-2027 (%)
o 7.5 Allergic rhinitis – Market size and forecast 2022-2027
o Exhibit 60: Chart on Allergic rhinitis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Allergic rhinitis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Allergic rhinitis – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Allergic rhinitis – Year-over-year growth 2022-2027 (%)
o 7.6 Cystic fibrosis – Market size and forecast 2022-2027
o Exhibit 64: Chart on Cystic fibrosis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Cystic fibrosis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Cystic fibrosis – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Cystic fibrosis – Year-over-year growth 2022-2027 (%)
o 7.7 Other respiratory diseases – Market size and forecast 2022-2027
o Exhibit 68: Chart on Other respiratory diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Other respiratory diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Other respiratory diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Other respiratory diseases – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Type
o Exhibit 72: Market opportunity by Type ($ billion)
o Exhibit 73: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 87: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 107: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 111: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 123: Abbott Laboratories – Overview
o Exhibit 124: Abbott Laboratories – Business segments
o Exhibit 125: Abbott Laboratories – Key news
o Exhibit 126: Abbott Laboratories – Key offerings
o Exhibit 127: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 128: AbbVie Inc. – Overview
o Exhibit 129: AbbVie Inc. – Product / Service
o Exhibit 130: AbbVie Inc. – Key news
o Exhibit 131: AbbVie Inc. – Key offerings
o 12.5 Aerogen Pharma Ltd.
o Exhibit 132: Aerogen Pharma Ltd. – Overview
o Exhibit 133: Aerogen Pharma Ltd. – Product / Service
o Exhibit 134: Aerogen Pharma Ltd. – Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 135: AstraZeneca Plc – Overview
o Exhibit 136: AstraZeneca Plc – Product / Service
o Exhibit 137: AstraZeneca Plc – Key news
o Exhibit 138: AstraZeneca Plc – Key offerings
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 139: Boehringer Ingelheim International GmbH – Overview
o Exhibit 140: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 141: Boehringer Ingelheim International GmbH – Key news
o Exhibit 142: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 143: Boehringer Ingelheim International GmbH – Segment focus
o 12.8 Celon Pharma SA
o Exhibit 144: Celon Pharma SA – Overview
o Exhibit 145: Celon Pharma SA – Business segments
o Exhibit 146: Celon Pharma SA – Key offerings
o Exhibit 147: Celon Pharma SA – Segment focus
o 12.9 Cipla Ltd.
o Exhibit 148: Cipla Ltd. – Overview
o Exhibit 149: Cipla Ltd. – Business segments
o Exhibit 150: Cipla Ltd. – Key news
o Exhibit 151: Cipla Ltd. – Key offerings
o Exhibit 152: Cipla Ltd. – Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 153: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 154: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 155: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 156: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 157: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 158: GlaxoSmithKline Plc – Overview
o Exhibit 159: GlaxoSmithKline Plc – Business segments
o Exhibit 160: GlaxoSmithKline Plc – Key news
o Exhibit 161: GlaxoSmithKline Plc – Key offerings
o Exhibit 162: GlaxoSmithKline Plc – Segment focus
o 12.12 Glenmark Pharmaceuticals Ltd.
o Exhibit 163: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 164: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 165: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.13 Lupin Ltd.
o Exhibit 166: Lupin Ltd. – Overview
o Exhibit 167: Lupin Ltd. – Product / Service
o Exhibit 168: Lupin Ltd. – Key news
o Exhibit 169: Lupin Ltd. – Key offerings
o 12.14 Novartis AG
o Exhibit 170: Novartis AG – Overview
o Exhibit 171: Novartis AG – Business segments
o Exhibit 172: Novartis AG – Key offerings
o Exhibit 173: Novartis AG – Segment focus
o 12.15 Sumitomo Pharma Co. Ltd.
o Exhibit 174: Sumitomo Pharma Co. Ltd. – Overview
o Exhibit 175: Sumitomo Pharma Co. Ltd. – Business segments
o Exhibit 176: Sumitomo Pharma Co. Ltd. – Key offerings
o Exhibit 177: Sumitomo Pharma Co. Ltd. – Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 178: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 179: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 180: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 181: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 182: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Vertex Pharmaceuticals Inc.
o Exhibit 183: Vertex Pharmaceuticals Inc. – Overview
o Exhibit 184: Vertex Pharmaceuticals Inc. – Product / Service
o Exhibit 185: Vertex Pharmaceuticals Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 186: Inclusions checklist
o Exhibit 187: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 188: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 189: Research methodology
o Exhibit 190: Validation techniques employed for market sizing
o Exhibit 191: Information sources
o 13.5 List of abbreviations
o Exhibit 192: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global respiratory drugs market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Type – Market share 2022-2027 (%)
Exhibits49: Data Table on Type – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Asthma – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Asthma – Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Asthma – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Asthma – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on COPD – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on COPD – Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on COPD – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on COPD – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Allergic rhinitis – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Allergic rhinitis – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Allergic rhinitis – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Allergic rhinitis – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Cystic fibrosis – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Cystic fibrosis – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Cystic fibrosis – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Cystic fibrosis – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Other respiratory diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Other respiratory diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Other respiratory diseases – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Other respiratory diseases – Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Type ($ billion)
Exhibits73: Data Table on Market opportunity by Type ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories – Overview
Exhibits124: Abbott Laboratories – Business segments
Exhibits125: Abbott Laboratories – Key news
Exhibits126: Abbott Laboratories – Key offerings
Exhibits127: Abbott Laboratories – Segment focus
Exhibits128: AbbVie Inc. – Overview
Exhibits129: AbbVie Inc. – Product / Service
Exhibits130: AbbVie Inc. – Key news
Exhibits131: AbbVie Inc. – Key offerings
Exhibits132: Aerogen Pharma Ltd. – Overview
Exhibits133: Aerogen Pharma Ltd. – Product / Service
Exhibits134: Aerogen Pharma Ltd. – Key offerings
Exhibits135: AstraZeneca Plc – Overview
Exhibits136: AstraZeneca Plc – Product / Service
Exhibits137: AstraZeneca Plc – Key news
Exhibits138: AstraZeneca Plc – Key offerings
Exhibits139: Boehringer Ingelheim International GmbH – Overview
Exhibits140: Boehringer Ingelheim International GmbH – Business segments
Exhibits141: Boehringer Ingelheim International GmbH – Key news
Exhibits142: Boehringer Ingelheim International GmbH – Key offerings
Exhibits143: Boehringer Ingelheim International GmbH – Segment focus
Exhibits144: Celon Pharma SA – Overview
Exhibits145: Celon Pharma SA – Business segments
Exhibits146: Celon Pharma SA – Key offerings
Exhibits147: Celon Pharma SA – Segment focus
Exhibits148: Cipla Ltd. – Overview
Exhibits149: Cipla Ltd. – Business segments
Exhibits150: Cipla Ltd. – Key news
Exhibits151: Cipla Ltd. – Key offerings
Exhibits152: Cipla Ltd. – Segment focus
Exhibits153: F. Hoffmann La Roche Ltd. – Overview
Exhibits154: F. Hoffmann La Roche Ltd. – Business segments
Exhibits155: F. Hoffmann La Roche Ltd. – Key news
Exhibits156: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits157: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits158: GlaxoSmithKline Plc – Overview
Exhibits159: GlaxoSmithKline Plc – Business segments
Exhibits160: GlaxoSmithKline Plc – Key news
Exhibits161: GlaxoSmithKline Plc – Key offerings
Exhibits162: GlaxoSmithKline Plc – Segment focus
Exhibits163: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits164: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits165: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits166: Lupin Ltd. – Overview
Exhibits167: Lupin Ltd. – Product / Service
Exhibits168: Lupin Ltd. – Key news
Exhibits169: Lupin Ltd. – Key offerings
Exhibits170: Novartis AG – Overview
Exhibits171: Novartis AG – Business segments
Exhibits172: Novartis AG – Key offerings
Exhibits173: Novartis AG – Segment focus
Exhibits174: Sumitomo Pharma Co. Ltd. – Overview
Exhibits175: Sumitomo Pharma Co. Ltd. – Business segments
Exhibits176: Sumitomo Pharma Co. Ltd. – Key offerings
Exhibits177: Sumitomo Pharma Co. Ltd. – Segment focus
Exhibits178: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits179: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits180: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits181: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits182: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits183: Vertex Pharmaceuticals Inc. – Overview
Exhibits184: Vertex Pharmaceuticals Inc. – Product / Service
Exhibits185: Vertex Pharmaceuticals Inc. – Key offerings
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations
